Suraksha Diagnostic IPO GMP today was ₹0, which meant shares were trading at their issue price of ₹441 with no premium or discount in the grey market according to investorgain.com.

Nuclear Medicine Market OverviewThe global nuclear medicine market is poised to experience substantial growth, projected to ...

The issue size of the Suraksha Diagnostic Limited IPO is Rs 846.25 crore which comprises an offer for sale (OFS) of 1.91 ...

Read Suraksha Diagnostic IPO Review and Analysis on The Economic Times. Find out Suraksha Diagnostic IPO Issue Price, Subscription Dates and Status, Suraksha Diagnostic IPO Listing Date and more.

The following is a summary of “Age at type 2 diabetes diagnosis and the risk of mortality among US population,” published in the November 2024 issue of Endocrinology by Zhang et al. Type 2 diabetes ...

Furthermore, the current lack of treatment options may also influence the acceptance of the proposed diagnosis. Summary: Bodily distress syndrome is a diagnostic category with notable validity ...

The following is a summary of “Higher healthcare cost and utilization before and after diagnosis of AATD in the United States ...

The ACR has released a summary of a new 2024 guideline for the screening, treatment, and management of Lupus Nephritis.

Smartphone addiction is a real issue, especially among younger people who can experience withdrawal symptoms when not ...

Advance Ruling No. KAR ADRG 41/2024, 13/11/2024, the Karnataka AAR ruled that an aggregator providing diagnostic and wellness services via a digital platform is taxable at 18% GST. The company, acting ...

Identification of red flag combinations of symptoms and signs should raise the index of suspicion of bacterial meningitis or meningococcal disease A senior clinical decision maker should perform an ...

3 Department of Child Health, Neurosciences Unit, UCL-Institute of Child Health, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK Correspondence to Dr Richard E Appleton, ...